This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Apr;16(4):507-508.

doi: 10.1016/j.jtho.2021.01.1606.

Too Good to be True?

Martin Sebastian¹, Jan Alexander Stratmann², Wilfried E E Eberhardt³

Affiliations

Affiliations

¹ Department of Medicine, University of Frankfurt, Frankfurt, Germany. Electronic address: martin.sebastian@kgu.de.
² Department of Medicine, University of Frankfurt, Frankfurt, Germany.
³ Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

PMID: 33781437
DOI: 10.1016/j.jtho.2021.01.1606

Free article

Editorial

Too Good to be True?

Martin Sebastian et al. J Thorac Oncol. 2021 Apr.

Free article

. 2021 Apr;16(4):507-508.

doi: 10.1016/j.jtho.2021.01.1606.

Authors

Martin Sebastian¹, Jan Alexander Stratmann², Wilfried E E Eberhardt³

Affiliations

¹ Department of Medicine, University of Frankfurt, Frankfurt, Germany. Electronic address: martin.sebastian@kgu.de.
² Department of Medicine, University of Frankfurt, Frankfurt, Germany.
³ Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

PMID: 33781437
DOI: 10.1016/j.jtho.2021.01.1606

No abstract available

PubMed Disclaimer

Comment on

Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC.
Chu T, Zhong R, Zhong H, Zhang B, Zhang W, Shi C, Qian J, Zhang Y, Chang Q, Zhang X, Dong Y, Teng J, Gao Z, Qiang H, Nie W, Zhao Y, Han Y, Chen Y, Han B. Chu T, et al. J Thorac Oncol. 2021 Apr;16(4):643-652. doi: 10.1016/j.jtho.2020.11.026. Epub 2021 Jan 29. J Thorac Oncol. 2021. PMID: 33524601 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information